Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12582684 | Compositions and methods for the treatment of wounds, disorders, and diseases of the skin | 🖼🧊📄§ | 2026-03-24 | 2043-06-27 | 0 | 31 |
| 12584149 | Nuclease-mediated genome editing of primary cells and related kits | 🖼🧊📄§ | 2026-03-24 | 2042-12-05 | 0 | 31 |
| 12583912 | Flavivirus cross neutralizing antibody and pharmaceutical composition | 🖼🧊📄§ | 2026-03-24 | 2041-02-04 | 0 | 31 |
| 12583907 | Modified plasma clotting factor VIII and method of use thereof | 🖼🧊📄§ | 2026-03-24 | 2043-09-15 | 0 | 31 |
| 12583904 | Articles of manufacture and methods for treatment using adoptive cell therapy | 🖼🧊📄§ | 2026-03-24 | 2044-09-11 | 0 | 31 |
| 12583939 | Bispecific antigen binding molecules that bind HER2, and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2044-03-08 | 0 | 31 |
| 12583917 | IL17A antibodies and antagonists for veterinary use | 🖼🧊📄§ | 2026-03-24 | 2042-03-04 | 0 | 31 |
| 12582714 | Methods and compositions for freezing and thawing mammalian cells | 🖼🧊📄§ | 2026-03-24 | 2043-07-28 | 0 | 31 |
| 12583921 | Targeted anti-SGLT1 avian IgY antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes | 🖼🧊📄§ | 2026-03-24 | 2043-04-26 | 0 | 31 |
| 12582956 | Articles of manufacture with polyurea capsules cross-linked with chitosan | 🖼🧊📄§ | 2026-03-24 | 2041-02-12 | 0 | 31 |
| 12582720 | Compound for preventing or treating lipid metabolism-related diseases | 🖼🧊📄§ | 2026-03-24 | 2041-04-23 | 0 | 31 |
| 12583967 | Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof | 🖼🧊📄§ | 2026-03-24 | 2043-02-13 | 0 | 31 |
| 12584114 | Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse | 🖼🧊📄§ | 2026-03-24 | 2044-01-03 | 0 | 31 |
| 12583972 | Non-isocyanate polyurethane elastomers and compositions comprising such elastomers | 🖼🧊📄§ | 2026-03-24 | 2041-05-12 | 0 | 31 |
| 12583896 | Caged-degron-based molecular feedback circuits and methods of using the same | 🖼🧊📄§ | 2026-03-24 | 2040-01-06 | 0 | 31 |
| 12582212 | Mesh-type moisture-release cushion cosmetic product | 🖼🧊📄§ | 2026-03-24 | 2039-10-08 | 0 | 31 |
| 12583873 | Amino acid mineral complex having immunopotentiating activity and composition for foods, pharmaceuticals, or feeds comprising same | 🖼🧊📄§ | 2026-03-24 | 2038-11-26 | 0 | 31 |
| 12582666 | Low dose therapeutic treatment | 🖼🧊📄§ | 2026-03-24 | 2043-10-12 | 0 | 31 |
| 12583900 | Peptide conjugates and methods of use | 🖼🧊📄§ | 2026-03-24 | 2040-12-03 | 0 | 31 |
| 12582626 | Methods and compositions for treating cancer | 🖼🧊📄§ | 2026-03-24 | 2042-06-07 | 0 | 31 |
| 12583942 | Anti-tetrodotoxin antibody K548, and preparation method and use thereof | 🖼🧊📄§ | 2026-03-24 | 2042-12-20 | 0 | 31 |
| 12583882 | Equatorially modified polymer linked multimers of guansine-3′, 5′-cyclic monophosphates | 🖼🧊📄§ | 2026-03-24 | 2042-08-08 | 0 | 31 |
| 12582619 | Compounds, compositions, and methods for treating or ameliorating, or preventing viral infections | 🖼🧊📄§ | 2026-03-24 | 2041-03-30 | 0 | 31 |
| 12583943 | Anti-tetrodotoxin antibody C31K8, and preparation method and use thereof | 🖼🧊📄§ | 2026-03-24 | 2042-12-20 | 0 | 31 |
| 12582614 | Composition for preventing, alleviating or treating sarcopenia, containing D-ribo-2-hexulose as active ingredient | 🖼🧊📄§ | 2026-03-24 | 2042-03-04 | 0 | 31 |
| 12584146 | Synthetic modified vaccinia Ankara (SMVA) based coronavirus vaccines | 🖼🧊📄§ | 2026-03-24 | 2045-04-18 | 0 | 31 |
| 12582613 | Biomimetic, reactive oxygen species-detonable nanoclusters for antirestenotic therapy | 🖼🧊📄§ | 2026-03-24 | 2042-07-21 | 0 | 31 |
| 12582652 | 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator | 🖼🧊📄§ | 2026-03-24 | 2044-10-25 | 0 | 31 |
| 12582670 | Lignin solvation using aqueous biologically compatible buffers | 🖼🧊📄§ | 2026-03-24 | 2040-01-10 | 0 | 31 |
| 12582723 | Polynucleotides encoding a human FKRP protein | 🖼🧊📄§ | 2026-03-24 | 2043-03-02 | 0 | 31 |
| 12582672 | Vanadium compositions and methods for treatment of cancer | 🖼🧊📄§ | 2026-03-24 | 2039-11-13 | 0 | 31 |
| 12582685 | Uses of saccharides from prasinococcales | 🖼🧊📄§ | 2026-03-24 | 2041-07-27 | 0 | 31 |
| 12582680 | Pharmaceutical composition for prevention, amelioration, or treatment of skin disease | 🖼🧊📄§ | 2026-03-24 | 2040-02-03 | 0 | 31 |
| 12582676 | Hydrogel particle encapsulated viable cells for in vivo regenerative treatment | 🖼🧊📄§ | 2026-03-24 | 2043-07-18 | 0 | 31 |
| 12582645 | Chemokine CXCR4 receptor modulators and uses related thereto | 🖼🧊📄§ | 2026-03-24 | 2044-05-03 | 0 | 31 |
| 12582678 | Method for treating pleural effusion | 🖼🧊📄§ | 2026-03-24 | 2042-09-30 | 0 | 31 |
| 12582662 | Injectable pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent and a preservative | 🖼🧊📄§ | 2026-03-24 | 2043-05-26 | 0 | 31 |
| 12582725 | AAV vectors with myelin protein zero promoter and uses thereof for treating SCHWANN cell-associated diseases like CHARCOT-MARIE-TOOTH disease | 🖼🧊📄§ | 2026-03-24 | 2040-06-03 | 0 | 31 |
| 12582146 | Angiotensin-converting enzyme inhibitor, blood pressure-lowering agent, and beverages and food products | 🖼🧊📄§ | 2026-03-24 | 2040-09-02 | 0 | 31 |
| 12582696 | Debaryomyces species as an indicator of non-healing ulcers in Crohn's disease | 🖼🧊📄§ | 2026-03-24 | 2040-12-10 | 0 | 31 |
| 12582697 | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure | 🖼🧊📄§ | 2026-03-24 | 2039-06-26 | 0 | 31 |
| 12582690 | Compositions for preventing or treating cancer comprising extracts of Rubus longisepalus var. tozawai (nakai) t.b.lee | 🖼🧊📄§ | 2026-03-24 | 2042-10-07 | 0 | 31 |
| 12582691 | Administration of Yunnan Baiyao or Xingnaojing in patients with moderate-to-severe traumatic brain injury and craniotomy | 🖼🧊📄§ | 2026-03-24 | 2042-07-12 | 0 | 31 |
| 12583844 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-11-13 | 0 | 31 |
| 12584919 | Enhancing anti-tumor response in melanoma cells with defective sting signaling | 🖼🧊📄§ | 2026-03-24 | 2042-09-16 | 0 | 31 |
| 12583832 | Cannabinoid analogs, formulations, and methods of use | 🖼🧊📄§ | 2026-03-24 | 2045-09-04 | 0 | 31 |
| 12583860 | Processes for the preparation of multicomponent crystalline forms of active pharmaceutical ingredients using solvent vapour | 🖼🧊📄§ | 2026-03-24 | 2041-02-24 | 0 | 31 |
| 12582500 | Methods and systems to automate surgical interventions | 🖼🧊📄§ | 2026-03-24 | 2043-07-28 | 0 | 31 |
| 12583894 | Materials and methods for the treatment of Lewy body disorders | 🖼🧊📄§ | 2026-03-24 | 2039-04-03 | 0 | 31 |
| 12582649 | Compositions and methods for hair follicle regeneration | 🖼🧊📄§ | 2026-03-24 | 2041-06-03 | 0 | 31 |